脓毒症患者血清胆碱酯酶变化及其临床意义

目的:探讨脓毒症患者血清胆碱酯酶(cholinesterase,ChE)变化及其临床意义.方法:检测患者血清ChE浓度,并进行急性生理学与慢性健康状况(APACHE)Ⅱ评分.根据是否发生脓毒血症将患者分为脓毒症组和对照组,其中脓毒症患者分为死亡组和存活组,了解组间血清ChE水平变化及其对病情和预后的影响.结果:(1)脓毒症患者血清ChE水平低于对照组患者(P＜0.01).(2)脓毒症患者死亡组血清ChE水平明显低于存活组(P＜0.05).(3)脓毒症患者血清ChE水平与其APACHE Ⅱ评分呈负相关(r=-0.280,P＜0.05).与血清白蛋白和体质量指数呈正相关(r分别为0.458和0.287,P＜0.05).结论:血清ChE水平可用于判断脓毒症患者病情严重程度及预后.

Serum Cholinesterase and Its Clinical Significance in Patients with Sepsis

Objective:To explore the changes of serum cholinesterase(ChE)and its clinical significance in patients with sepsis.Methods:Serum cholinesterase concentration,acute physiology and chronic health evaluation(APACHE)Ⅱ scores were estimated in patients.The patients in this study were divided into the sepsis group and the non-sepsis group.The patients with sepsis were further divided into the death group and the survival group.The influence of altered serum ChE levels on prognosis was compared between the groups.Results:(1)Serum ChE was significantly lower in patients of sepsis group than that of control group(P ＜ 0.01).(2)In patients with sepsis,the serum ChE level was significantly lower in the death group compared with that of survival group(P ＜ 0.05).(3)In patients with sepsis the serum ChE levels were significantly negatively correlated with APACHE Ⅱ scores(r=-0.280,P ＜ 0.05),positively correlated with serum albumin and body mass index(r=0.458 and 0.287,P ＜ 0.05).Conclusion:Serum ChE levels can be used to determine the prognosis and severity of illness in patients with sepsis.